Buchholz, Sarah ORCID: 0000-0002-3636-1364 and Zempel, Hans ORCID: 0000-0002-7510-3077 (2024). The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes. Alzheimer's & Dementia, 20 (5). pp. 3606-3628. Wiley. ISSN 1552-5260

[thumbnail of Alzheimer s Dementia - 2024 - Buchholz - The six brain‐specific TAU isoforms and their role in Alzheimer s disease and.pdf] PDF
Alzheimer s Dementia - 2024 - Buchholz - The six brain‐specific TAU isoforms and their role in Alzheimer s disease and.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB)
Identification Number:10.1002/alz.13784

Abstract

Introduction: Alternative splicing of the human MAPT gene generates six brain‐specific TAU isoforms. Imbalances in the TAU isoform ratio can lead to neurodegenerative diseases, underscoring the need for precise control over TAU isoform balance. Tauopathies, characterized by intracellular aggregates of hyperphosphorylated TAU, exhibit extensive neurodegeneration and can be classified by the TAU isoforms present in pathological accumulations. Methods: A comprehensive review of TAU and related dementia syndromes literature was conducted using PubMed, Google Scholar, and preprint server. Results: While TAU is recognized as key driver of neurodegeneration in specific tauopathies, the contribution of the isoforms to neuronal function and disease development remains largely elusive. Discussion: In this review we describe the role of TAU isoforms in health and disease, and stress the importance of comprehending and studying TAU isoforms in both, physiological and pathological context, in order to develop targeted therapeutic interventions for TAU‐associated diseases. Highlights: MAPT splicing is tightly regulated during neuronal maturation and throughout life. TAU isoform expression is development‐, cell‐type and brain region specific. The contribution of TAU to neurodegeneration might be isoform‐specific. Ineffective TAU‐based therapies highlight the need for specific targeting strategies.

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Buchholz, Sarah
UNSPECIFIED
UNSPECIFIED
Zempel, Hans
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-816353
Identification Number: 10.1002/alz.13784
Journal or Publication Title: Alzheimer's & Dementia
Volume: 20
Number: 5
Page Range: pp. 3606-3628
Number of Pages: 23
Date: 31 May 2024
Publisher: Wiley
ISSN: 1552-5260
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Humangenetik > Institut für Humangenetik
Zentrum für Molekulare Medizin
Subjects: Life sciences
Medical sciences Medicine
Uncontrolled Keywords:
Keywords
Language
alternative splicing ; Alzheimer’s disease ; genetic tauopathy ; MAPT ; TAU isoforms ; tauopathy
English
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/81635

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item